Scout | Biology of Bladder Cancer (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Biology of Bladder Cancer (R01 Clinical Trial Optional)

This grant opportunity invites research applications focused on understanding the biology and mechanisms of bladder cancer. Bladder cancer poses a significant health issue due to its high incidence and recurrence, contributing to a substantial medical burden. Despite recent advances in identifying genetic mutations, the molecular processes behind the initiation and progression of bladder cance…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Dates

Opportunity Released: July 26, 2022

Open for Submission: July 26, 2022

Submission Deadline: September 7, 2025

Application Window Closes: September 7, 2025

Keywords

bladder cancer

molecular mechanisms

tumor recurrence

cancer biology

genetic mutations

cellular functions

multidisciplinary research

clinical specimens

cancer progression

molecular profiling

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers